Showing results (691-700 of 928) with videos related to
Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|November 7, 2017
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trialAneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.The Lancet. Diabetes & Endocrinology|July 6, 2026
Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trialJing Luo, Sylvia Kehlenbrink, Chung-Chou H Chang, et al.The Lancet. Diabetes & Endocrinology|May 14, 2026
Is weight cycling clinically harmful?Faidon Magkos, Norbert StefanThe Lancet. Diabetes & Endocrinology|May 15, 2026
Type 1 diabetes intervention clusters in resource-limited settings: a systematic review and economic evaluationSanjay Basu, Jessica Hanae Zafra-Tanaka, David BeranThe Lancet. Diabetes & Endocrinology|May 11, 2026
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trialSophia Zoungas, David D'Alessio, Imre Pavo, et al.The Lancet. Diabetes & Endocrinology|December 9, 2014
Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling studySteven A Grover, Mohammed Kaouache, Philip Rempel, et al.The Lancet. Diabetes & Endocrinology|December 4, 2014
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million peopleAnoop Dinesh Shah, Claudia Langenberg, Eleni Rapsomaniki, et al.The Lancet. Diabetes & Endocrinology|December 4, 2014
Diabetes in older people: new insights and remaining challengesAlan Sinclair, Trisha Dunning, Leocadio Rodriguez-MañasThe Lancet. Diabetes & Endocrinology|December 4, 2014
Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort studyHelen Booth, Omar Khan, Toby Prevost, et al.The Lancet. Diabetes & Endocrinology|October 23, 2015
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trialMorris J Brown, Bryan Williams, Steve V Morant, et al.Pageof 93